| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a933a0dd561e3e50b278738704d5c6e6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-14 |
| filingDate |
2005-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1197fb5593cc9007ac1916b8ab9f86b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eece0949460cb5d7bc93547ff6a679a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_503d2c5e0fd04d0a1aac2cedbc6047cf |
| publicationDate |
2011-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1781622-B1 |
| titleOfInvention |
Integrin alpha-v beta-3 antagonists for use in imaging and therapy |
| abstract |
Integrin receptor antagonists whose molecular structure includes a tetrahydropyridimidinylaminoethyloxybenzoyl group on a sulfonylamino-β-alanine nucleus exhibit increased binding affinity for the αvβ3 receptor when further substituted on the sulfonyl moiety with an N-amino alkycarbamyl group or a butyloxycarbonylamino alkylcarbamoyl group or similar groups. Formula (I): |
| priorityDate |
2004-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |